Concepedia

Pascal Egger

PE

Statistics

Publications

3

Citations

199

H-Index

3

Active since

2002

Affiliations

Inserm(Current)

Pfizer (France)

Erasmus University Rotterdam

Pascal Egger is an author at Inserm specializing in lipoprotein metabolism, cholesterol metabolism, and lipid biochemistry.

Publications per year

2002–2002

3

Publications

3

Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux

Maryse Guérin, Pascal Egger, Céline Soudant et al. · Atherosclerosis · 2002 · 100 citations

, , +17

Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state

Maryse Guérin, Pascal Egger, Céline Soudant et al. · Journal of Lipid Research · 2002 · 67 citations · Full text

, , +15

Atorvastatin Reduces Postprandial Accumulation and Cholesteryl Ester Transfer Protein-Mediated Remodeling of Triglyceride-Rich Lipoprotein Subspecies in Type IIB Hyperlipidemia

Maryse Guérin, Pascal Egger, Wilfried Le Goff et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 32 citations · Full text

, , +17

1–3 of 3